Last updated on November 2017

Diabetic Gastroparesis

Brief description of study

Diabetic Gastroparesis

Detailed Study Description

A phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of RM -131 administered to patients with diabetic gastroparesis

Clinical Study Identifier: TX2717

Contact Investigators or Research Sites near you

Start Over

Wake Research Associates

Wake Research Associates
Raleigh, NC USA

Robert Hardi, MD, AGAF, CPI

MGG Group Co., Inc., Chevy Chase Clinical Research
Chevy Chase, MD USA